VistaGen Therapeutics Inc (VTGN) support and resistance · rev $1.3M
VistaGen Therapeutics Inc (VTGN) is a biotechnology company listed on NASDAQ.
This page maps VistaGen Therapeutics Inc (VTGN) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported VTGN revenue for 2026-03-31 was $1.3M. Net income was -$69.7M. Revenue was up 161.1% from 2025-03-31 to 2026-03-31. VTGN currently screens at market cap $28.1M.
VTGN currently screens at market cap $28.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new VTGN 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the VTGN quote page for the session range and the stock page for the full model.
Not investment advice.